EMS 12-Lead

APRIL 9, 2024

There is increased LV cavity dimensions with an increase in transient ischemic dilation, suggesting Left Main, or 3-vessel coronary artery disease. Sudden narrowing of a coronary artery due to ACS (plaque rupture with thrombosis and/or downstream showering of platelet-fibrin aggregates). Type I ischemia.

Ischemia 116

Ischemia Stenosis Chest Pain Coronary Artery Disease 116

DAIC

OCTOBER 16, 2024

Notably, the Supraflex Cruz stent showed a significant reduction in clinically driven target lesion revascularization (TLR) rates and very low rates of stent thrombosis, despite the fact that the enrolled patients were at substantial risk for bleeding and ischemic events. Principal Investigator, Dr. Pieter C.

Stents 52

Stents Stent Thrombosis Coronary Artery Disease 52

The British Journal of Cardiology

OCTOBER 8, 2024

That, it was possible to treat atherosclerotic coronary artery disease with an updated Andreas Grüntzig’s balloon alone, without the safety net and comfort of implanting a single stent. It was unprecedented, going against received wisdom.

Coronary Artery Disease 40

Coronary Artery Disease Stents Stent Hospital 40

Circulation

NOVEMBER 11, 2024

Coronary angiography revealed a tortuous and extremely aneurysmal RCA, as well as multivessel coronary artery disease (mvCAD) involving LAD, D1, LCx, OM1. Multislice CT angiography further characterized the RCA, which extends to the coronary sinus (CS) distally forming a coronary cameral fistula (CCF).

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft ACE Inhibitor Coronary Angiogram Aneurysm 40

Circulation

NOVEMBER 11, 2024

Introduction:Subacute stent thrombosis (ST) is related to high rates of cardiac reinfarction. The patient’s chest pain (CP) was not alleviated with initial revascularization of his left circumflex (LCx) ST, requiring PCI to his right coronary artery (RCA) chronic total occlusion (CTO). We present a case of reinfarction from ST.

Chest Pain 40

Chest Pain Coronary Artery Disease Angioplasty Thrombosis 40

Dr. Smith's ECG Blog

NOVEMBER 30, 2022

Hospital Course The patient was taken emergently to the cath lab which did not reveal any significant coronary artery disease, but she was noted to have reduced EF consistent with Takotsubo cardiomyopathy. The degree of stenosis is not a great predictor of thrombosis, and culprits may not be visible. Lindahl et al.

Plaque 52

Plaque Chest Pain Thrombosis Stenosis 52

Stroke Journal

JANUARY 30, 2025

Adverse vascular outcomes used as endpoints include acute ischemic stroke, acute myocardial infarction, deep vein thrombosis/pulmonary embolism, AF, and carotid artery dissection.A Patients with any adverse vascular outcomes before the index ECG were excluded. The mean age at the time of the index ECG was 44.3

Atrial Fibrillation 40

Atrial Fibrillation Outcomes Coronary Artery Disease Myocardial Infarction 40

Dr. Smith's ECG Blog

JANUARY 27, 2024

Old ‘NSTEMI’ A history of coronary artery disease and a stent to the same territory further increases pre-test likelihood of acute coronary occlusion, including in-stent thrombosis.

Chest Pain 117

Chest Pain STEMI Aneurysm Stents 117

Dr. Smith's ECG Blog

MAY 19, 2020

MINOCA: Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease). Here is my comment on MINOCA: "Non-obstructive coronary disease" does not necessarily imply "no plaque rupture with thrombus." 2) overlooked obstructive coronary disease (e.g., What is MINOCA? myocarditis).

Defibrillator 52

Defibrillator Circulation Plaque Cardiac Arrest 52

Dr. Smith's ECG Blog

NOVEMBER 4, 2022

Diffuse ST depression with ST elevation in aVR: Is this pattern specific for global ischemia due to left main coronary artery disease? Incidence of an acute coronary occlusion. Diffuse ST depression with ST elevation in aVR: Is this pattern specific for global ischemia due to left main coronary artery disease?

Ischemia 52

Ischemia STEMI Stenosis Chest Pain 52

Dr. Smith's ECG Blog

SEPTEMBER 9, 2024

You can easily imagine this patient getting one of several diagnoses -- vasospasm, MINOCA , pericarditis, or maybe even no diagnosis at all beyond "non-obstructive coronary artery disease." Smith comment : a very high proportion of MINOCA are ruptured plaque with lysed thrombus. That plaque is at risk of thrombosing again.

Plaque 66

Plaque Stents Stent Chest Pain 66

The British Journal of Cardiology

NOVEMBER 10, 2023

Andreas Grüntzig, an ardent angiologist crafted an indeflatable sausage-shaped dual-lumen balloon-catheter, designed its delivery to the heart, launched minimally invasive coronary intervention and taught by beaming live demonstration. Subsequent advances are just incremental tweaks and tinkers around this fully formed framework from 1978.

Stents 40

Stents Stent Coronary Artery Disease Myocardial Infarction 40

DAIC

APRIL 2, 2025

Stone, MD Mount Sinai Health System tim.hodson Wed, 04/02/2025 - 15:26 March 31, 2025 Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than conventional angiography, the more commonly used technique.

Stents 40

Stents Stent Outcomes Coronary Angiogram 40

Stroke Journal

FEBRUARY 1, 2024

Primary end point was a composite of ischemic stroke, myocardial infarction, or other arterial thrombotic events. Arterial thrombotic events occurred in 169 (9.7%) patients. CONCLUSIONS:Intracerebral hemorrhage survivors are at high long-term risk of arterial thrombosis. Stroke, Ahead of Print.

Thrombosis 40

Thrombosis Hemorrhage Coronary Artery Disease Myocardial Infarction 40

Circulation

NOVEMBER 11, 2024

A random-effects model was used for outcomes with high heterogeneity.Results:We included 4 RCTs with 3173 patients comparing FFR-guided CR with culprit-only PCI in patients with STEMI and multivessel coronary artery diseases. vs 13.6%), any stent thrombosis (RR=1.42; 95% CI [0.35, 5.72]; p=0.62; 2.2%

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Thrombosis 40

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

All About Cardiovascular System and Disorders

APRIL 21, 2024

FAME study showed that at one year follow up, rate of major adverse coronary events was reduced by approximately 30% by routinely measuring FFR. Usually a stent is considered in bifurcation disease only if the side branch is large and almost equal in size to the distal vessel. Cut off FFR was 0.8 in the study. J Am Coll Cardiol.

Myocardial Infarction 52

Myocardial Infarction Stents Stent Coronary Artery Disease 52

Open Heart

OCTOBER 26, 2022

Objectives Compare the safety and efficacy of BVS versus DES in patients receiving percutaneous coronary intervention for coronary artery disease across a complete range of randomised controlled trial (RCT) follow-up intervals.

Stents 52

Stents Stent Coronary Artery Disease Myocardial Infarction 52

Cardiology Update

FEBRUARY 14, 2024

In the early years of percutaneous coronary intervention (PCI), studies indicated a heightened risk of major adverse cardiac events (MACE) in patients with reduced left ventricular ejection fraction (LVEF), involving outcomes such as death, Q-wave myocardial infarction (MI), stent thrombosis, and repeat revascularization.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Thrombosis Research 52

Coronary Artery Disease Journal

MARCH 7, 2024

Although there is a favorable trend for major adverse cardiovascular and cerebrovascular events (MACCE), nonfatal AMI, cerebrovascular events, and major bleeding in the immediate non-culprit artery (-ies) PCI, those were statistically non-significant.

Myocardial Infarction 40

Myocardial Infarction Ischemia Thrombosis Stents 40

Coronary Artery Disease Journal

AUGUST 22, 2024

Data were extracted from published reports and quality assessment was performed per Cochrane recommendations. Statistical analysis was performed using Review Manager (Cochrane collaboration).

Myocardial Infarction 40

Myocardial Infarction Thrombosis Stents Stent 40

Cardiology Update

APRIL 9, 2024

The primary non-inferiority endpoint was MACCE (a composite of cardiac death, MI, ischaemic stroke, stent thrombosis, or target vessel revascularisation). The results advocate for considering PCI as a treatment option for such plaques, potentially expanding the indications for PCI in coronary artery disease management.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Open Heart

MAY 12, 2023

Objective Antithrombotic therapy is essential for patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) because of the high risk of thrombosis, whereas a combination of antiplatelets and anticoagulants is associated with a high risk of bleeding.

Coronary Artery Disease 52

Coronary Artery Disease Atrial Fibrillation Myocardial Infarction Blood Pressure 52

Journal of the American Heart Association

APRIL 7, 2025

Decedents with acute coronary thrombosis, myocardial infarction, or other myocardial abnormality were excluded. Journal of the American Heart Association, Ahead of Print. Decedents with either noncardiac death or SAD had similar height, weight, and heart weight. Moreover, decedents with SAD had lower cardiomyocyte width (mean, 18.6

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction Thrombosis Stenosis 40

Frontiers in Cardiovascular Medicine

MARCH 14, 2025

BackgroundAcute myocardial infarction commonly occurs in patients with coronary artery disease, but rarely, it can develop under a hypercoagulable state. These thrombotic complications predominantly arise in veins rather than in arteries. These thrombotic complications predominantly arise in veins rather than in arteries.

Myocardial Infarction 52

Myocardial Infarction Thrombosis Chest Pain Coronary Artery Disease 52

Frontiers in Cardiovascular Medicine

NOVEMBER 28, 2024

0.85, P = 0.004), target vessel revascularization (TVR) (P = 0.01), target lesion revascularization (TLR) (P = 0.03) and stent thrombosis (ST) (P = 0.002) in the experimental group (IVUS-guidance) was lower than that in the control group (non-IVUS-guidance). The results showed that the incidence of MACE (RR: 0.63, 95% CI: 0.49–0.82,

Stents 59

Stents Stent Coronary Artery Disease Myocardial Infarction 59

Dr. Smith's ECG Blog

MARCH 8, 2025

Angiography was technically challenging as the patient was receiving CPR, but the cardiologist suspected acute stent thrombosis and initiated cangrelor, although no repeat angiography was able to be obtained. Circumstances attending 100 sudden deaths from coronary artery disease with coroners necropsies. & Dewar, H.

Cardiomyopathy 75

Cardiomyopathy Myocardial Infarction Defibrillator Bradycardia 75